Why do I smell like maple syrup?

Sotolone, a fenugreek aroma compound, is excreted in sweat and urine. It is harmless and generally signals that you are absorbing an adequate dose.

Does it actually raise testosterone?

Modest increases appear in some male trials, but libido scores improve more consistently than hormone levels — so the benefit may not be hormonal.

Does it work for women?

A randomised trial in women reported improved desire and arousal at the same 600 mg dose. That is unusual in this category, though it is a single small trial.

Outcome

Moderate Evidence

Fenugreek for Libido Enhancement

Fenugreek seed extract improved libido scores in both men and women in RCTs using standardized extracts — one of the few botanicals with female libido data.

Overview

Libido is the outcome with the most consistent fenugreek evidence. Randomised placebo-controlled trials in both men and women, using 600 mg daily of standardised extract for six to eight weeks, report improvements in sexual desire, arousal and satisfaction scores versus placebo. It is also one of very few botanicals with female libido data rather than male-only extrapolation, which is why it appears here at all.

Two caveats keep this at 'likely' rather than settled. The trials are small and largely manufacturer-funded, and the libido effects appear more reliable than the accompanying testosterone changes — which suggests the mechanism may not be hormonal in the way the marketing claims.

At a glance

600 mg/day standardised extract

6-8 weeks to effect

RCT data in both men and women

Trials small and often industry-funded

Avoid in pregnancy

How It Works

The proposed mechanism centres on furostanolic saponins, which are thought to inhibit the enzymes that metabolise testosterone and thereby raise the free fraction. Aromatase modulation has been proposed as the route for the effects observed in women.

The mechanistic story sits awkwardly with the data. Desire and arousal scores improve more consistently than hormone measurements do, which points towards a central or subjective effect rather than a straightforwardly endocrine one. The honest position is that the effect is better documented than its explanation.

Key mechanisms

Furostanolic saponins as proposed actives

May raise free testosterone fraction

Aromatase modulation proposed in women

Hormone changes lag behind libido changes

Dosing & Protocol

Six hundred milligrams daily of a standardised furostanolic saponin extract, taken with a meal, is the studied dose. There is no titration — the dose is simply what was tested. Plain seed powder has not been tested at equivalent potency for this outcome and should not be assumed interchangeable.

Scenario	Dose	Form	Timing
Standard protocol	600 mg/day	Standardised furostanolic saponin extract	With a meal
Studied brands	600 mg/day	Testofen, Fenu-FG	As per trial protocol
Not equivalent	Culinary seed powder	Whole seed	Untested at this potency
Assessment window	6-12 weeks	—	Validated questionnaire at baseline and end

1
Score your baseline· Week 0
Use a validated sexual function questionnaire before starting. Recalled comparison is unreliable for this outcome.
2
Take 600 mg daily with food· Weeks 1-8
A standardised extract, at the fixed studied dose. No titration is needed or supported.
3
Expect the odour marker· Weeks 1-2
A maple-syrup body odour is common and simply indicates absorption of sotolone; it is not harmful.
4
Rescore at 8-12 weeks· Week 8-12
Same questionnaire, same conditions. Stop if scores are unchanged.

Signs it is working

Higher desire and arousal scores on a validated questionnaire

More spontaneous interest in sex

Improved satisfaction reported by the participant, not inferred from hormone levels

Better energy and mood alongside

Evidence

Trials of 600 mg daily standardised extracts, principally Testofen and Fenu-FG, show improved libido, sexual function scores and modest testosterone increases in men, and one randomised trial in women reported improved desire and arousal.

Sample sizes are small and much of the work is manufacturer-sponsored, which is a real limitation on confidence rather than a technicality. The consistency of direction across independent cohorts is what keeps the verdict at 'likely'.

No studies are currently linked to this pair in our database; citations are pending indexing and the summary above reflects the published trial literature for this outcome.

Safety

Fenugreek is a uterine stimulant and should be avoided in pregnancy. It belongs to the legume family, so cross-reactivity is possible in people with peanut or chickpea allergy. Gastrointestinal upset is common at the start, and fenugreek can lower blood sugar, which matters for anyone on glucose-lowering medication.

Cautions and non-responders

Avoid in pregnancy — uterine stimulant

Peanut and chickpea allergy cross-reactivity

GI upset common initially

May lower blood glucose

Not for hormonally mediated low libido needing clinical management

Interactions & Conflicts

The interactions worth planning around are metabolic and haematological. Fenugreek's glucose-lowering effect is additive with diabetes medication, and its coumarin content raises theoretical bleeding risk alongside anticoagulants. Low libido driven by menopause, hypogonadism or antidepressant treatment is a clinical problem and will not be solved here.

Interacts with	Severity	Mechanism	Action
		—	—
		—	—
		—	—
		—	—

References

References for this page are being indexed against our studies database. Where a claim rests on a specific trial, that trial is named in the evidence section above.

Frequently Asked Questions

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.